Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
PubMed Central , If you want the meta-analysis: If you want the meta-analysis: If you want the meta-analysis: 6 Ko, Jennifer, et al
& Le Cam, L
Thus, irrespective of the presence of the C-terminal L585 residue, QMP successfully competes for binding to human FcRn in vivo, resulting in an extended plasma half-life
Shruthi and M.Y
Exclusion criteria: (1) Patients with abnormal coagulation function [limits: prothrombin time (PT) between 1014 seconds, activated partial thromboplastin time (APTT) between 2540 seconds, and fibrinogen (Fib) levels between 2.04.0 g/L] and immunodeficiency [either primary immunodeficiency (congenital or hereditary conditions leading to impaired immune responses) or secondary immunodeficiency (conditions acquired through HIV infection, chronic immunosuppressive therapy, or severe malnutrition)]
US$ 20.04
US$ 24.32
US$ 26.07
US$ 25.93
US$ 29.69
US$ 21.45
US$ 25.43
US$ 27.95
